May 10, 1999Change in Control Agreement • February 29th, 2000 • Sonus Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledFebruary 29th, 2000 Company Industry Jurisdiction
1 September 15, 1998 Mr. Michael Martino c/o SONUS Pharmaceuticals, Inc. 22026 20th Avenue Bothell, Washington 98021 Re: Change In Control Agreement Dear Michael: In consideration of your employment with SONUS Pharmaceuticals, Inc., a Delaware...Change in Control Agreement • November 10th, 1998 • Sonus Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledNovember 10th, 1998 Company Industry Jurisdiction
1 September 15, 1998 Steven C. Quay, M.D., Ph.D. President and Chief Executive Officer c/o SONUS Pharmaceuticals, Inc. 22026 20th Avenue Bothell, Washington 98021 Re: Change In Control Agreement Dear Steve: In consideration of your employment with...Change in Control Agreement • November 10th, 1998 • Sonus Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledNovember 10th, 1998 Company Industry Jurisdiction
1 September 15, 1998 Mr. Greg Sessler Vice President and Chief Financial Officer c/o SONUS Pharmaceuticals, Inc. 22026 20th Avenue, Suite 201 Bothell, Washington 98021 Re: Change In Control Agreement Dear Greg: In consideration of your employment with...Change in Control Agreement • November 10th, 1998 • Sonus Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledNovember 10th, 1998 Company Industry Jurisdiction